Author

R. M. Gilbride

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:rat· 3 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

D. Malouli· 3 shared S. G. Hansen· 3 shared A. B. Ventura· 2 shared B. Berkemeier· 2 shared C. M. Hughes· 2 shared D. Morrow· 2 shared D. N. Streblow· 2 shared H. Taher· 2 shared

Activity by Year

2020-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

D. Malouli

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Rhesus Cytomegalovirus-encoded Fcγ-binding glycoproteins facilitate viral evasion from IgG-mediated humoral immunity

C. E. Otero, S. Petkova, M. Ebermann, H. Taher, N. John, K. Hoffmann, A. Davalos, M. J. Mostrom, R. M. Gilbride, C. Papen, A. Barber-Axthelm, E. A. Scheef, R. Barfield, L. M. Sprehe, S. Kendall, , P. Kolb

This study identifies and characterizes Rhesus CMV-encoded Fcγ-binding glycoproteins, showing they delay antibody-mediated immune control during primary infection.

Nature Communications · Jan 31, 2025Peer-reviewedMicrobiology

Cytomegaloviral determinants of CD8+ T cell programming and RhCMV/SIV vaccine efficacy

D. Malouli, S. G. Hansen, M. H. Hancock, C. M. Hughes, J. C. Ford, R. M. Gilbride, A. B. Ventura, D. Morrow, H. Taher, L. S. Uebelhoer, M. R. McArdle, C. R. Papen, R. Espinosa Trethewy, K. Oswald, R. Shoemaker, , L. J. Picker

This study identifies eight genes in two RhCMV regions that control unconventional CD8+ T cell responses and vaccine efficacy against SIV challenge.

bioRxiv · Sep 30, 2020Immunology

Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy

M. Verweij, S. G. Hansen, R. Iyer, N. John, D. Malouli, D. Morrow, I. Scholz, J. Womack, S. Abdulhaqq, R. M. Gilbride, C. M. Hughes, A. B. Ventura, J. C. Ford, A. N. Selseth, K. Oswald, , K. Früh

This study shows that the Rh67/UL40 protein in RhCMV/SIV vectors is necessary for MHC-E-restricted CD8+ T cell responses and SIV protection in rhesus macaques.

bioRxiv · Sep 30, 2020Immunology